Gestational diabetes & diabetes in pregnancy
Receipt of postpartum diabetes screening after gestational diabetes mellitus in the United States, 2016–2022
Authors' conclusion
While postpartum diabetes screening has increased and aligns with recognized risk factors, overall prevalence remains suboptimal.
Study context
- Population
- Postpartum individuals with self-reported gestational diabetes mellitus (GDM) who attended a postpartum checkup and reported on postpartum diabetes screening, Pregnancy Risk Assessment Monitoring System (PRAMS) 2016–2022, 44 U.S. states and jurisdictions
- Participants
- 21,559 individuals
- Outcome
- Prevalence of postpartum diabetes screening after GDM
Methodological detailspopulation-based, multivariable modified Poisson regression
- Population-based
- Multivariable modified Poisson regression
Main finding
As reported in the abstract
Overall weighted prevalence of postpartum diabetes screening · 2016-2022
Overall weighted prevalence of postpartum diabetes screening
55.8%
95% CI 54.8–56.9
Observational data: associations, not effects.
Further findings
Annual screening prevalence
- 2016
- 55.6%
- 2019
- 60.3%
- 2020 (onset of COVID-19 pandemic)
- 52.6%
- 2022
- 55.8%
Factors associated with higher screening prevalence
- Screening prevalence higher among individuals ≥30 years, racial or ethnic minoritized groups, did not graduate from high school, public prenatal health insurance, pre-pregnancy overweight or obesity, adequate plus prenatal care
- 6%-38% higher
Factors associated with lower screening prevalence
- Screening prevalence lower among individuals with a previous live birth, preterm birth, residents of rural areas, the South or U.S. Territories
- 5%-14% lower
Original publication
Receipt of postpartum diabetes screening after gestational diabetes mellitus in the United States, 2016–2022. Diabet Med. Published 10 April 2026. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →